| TCA | T-cell A locus; terminal cancer; tetracyclic antidepressant; total cholic acid; total circulating al... |
|---|---|
| MAOI | MonoAmine Oxidase Inhibitors |
| MAOI | monoamine oxidase inhibitor |
| TCAD | tricyclic antidepressant |
| MAOI | MAO inhibitor |
|---|---|
| MAOI | Monoamine oxidase inhibitor |
| AD | Antidepressant |
| AD | Antidepressant drug |
| TAD | Tricyclic antidepressant |
| MAOI | <pharmacology> A drug that interferes with the action of monoamine oxidase, slowing the breakdown of certain neurotransmitters. Used in the treatment of depression. Monoamine oxidase inhibitors are a group of antidepressant drugs that prevent the activity of the enzyme monoamine oxidase in the central nervous system (brain) thus affecting mood. The use of these medications is often restricted due to their severe side effects and drug (and food) interactions. Examples include isocarboxazid, pargyline, selegiline, furazolidone and phenelzine. Acronym: MAOI (26 Mar 1998) |
|---|---|
| antidepressant | An agent that stimulates the mood of a depressed patient, including tricyclic antidepressants and monoamine oxidase inhibitors. (18 Nov 1997) |
| tricyclic antidepressant | <pharmacology> A group of antidepressant medications that share chemical characteristics, side effects and toxicity. Examples include: amitriptyline, amoxapine, clomipramine, desipramine, imipramine, nortriptyline, trimipramine and protriptyline. (19 Jan 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|